{"id":"https://openalex.org/W1978349904","doi":"https://doi.org/10.1111/j.1600-0773.1986.tb00115.x","title":"Medroxyprogesterone Acetate Pharmacokinetics Following Oral High\u2010Dose Administration in Humans: A Bioavailability Evaluation of a New MPA Tablet Formulation","display_name":"Medroxyprogesterone Acetate Pharmacokinetics Following Oral High\u2010Dose Administration in Humans: A Bioavailability Evaluation of a New MPA Tablet Formulation","alternate_titles":[],"publication_year":1986,"publication_date":"1986-05-01","ids":{"openalex":"https://openalex.org/W1978349904","doi":"https://doi.org/10.1111/j.1600-0773.1986.tb00115.x","mag":"1978349904","pmid":"https://pubmed.ncbi.nlm.nih.gov/2943134"},"language":"en","primary_location":{"id":"doi:10.1111/j.1600-0773.1986.tb00115.x","doi":"https://doi.org/10.1111/j.1600-0773.1986.tb00115.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1600-0773.1986.tb00115.x","pdf_url":null,"source":{"id":"https://openalex.org/S4210230610","display_name":"Acta Pharmacologica et Toxicologica","issn_l":"0001-6683","issn":["0001-6683"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Pharmacologica et Toxicologica","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1978349904"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5009694714","display_name":"Elof D.B. Johansson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1342360035","display_name":"Uppsala University Hospital","ror":"https://ror.org/01apvbh93","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I1342360035"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"E. D. B. Johansson","raw_affiliation_strings":["Department of Gynaecology and Obstetrics, University Hospital, Uppsala, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Gynaecology and Obstetrics, University Hospital, Uppsala, Sweden","institution_ids":["https://openalex.org/I1342360035"]}]},{"author_position":"middle","author":{"id":null,"display_name":"P. B. Johansen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210165112","display_name":"Leo Pharma (Denmark)","ror":"https://ror.org/05tzrdd39","country_code":"DK","type":"company","lineage":["https://openalex.org/I4210124980","https://openalex.org/I4210165112"]}],"countries":["DK"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"P. B. Johansen","raw_affiliation_strings":["Leo Pharmaceutical Products Ltd., DK-2750 Ballerup"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leo Pharmaceutical Products Ltd., DK-2750 Ballerup","institution_ids":["https://openalex.org/I4210165112"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113587230","display_name":"S\u00f8ren N. Rasmussen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"S. N. Rasmussen","raw_affiliation_strings":["The Royal Danish School of Pharmacy, Department of Pharmacology, DK-2100 Copenhagen, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Royal Danish School of Pharmacy, Department of Pharmacology, DK-2100 Copenhagen, Denmark","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.3969,"has_fulltext":false,"cited_by_count":24,"citation_normalized_percentile":{"value":0.80208811,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":96},"biblio":{"volume":"58","issue":"5","first_page":"311","last_page":"317"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10600","display_name":"Reproductive Health and Contraception","score":0.25949999690055847,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10600","display_name":"Reproductive Health and Contraception","score":0.25949999690055847,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.2232999950647354,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12421","display_name":"Adrenal Hormones and Disorders","score":0.14110000431537628,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/medroxyprogesterone-acetate","display_name":"medroxyprogesterone acetate","score":1.0},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9200000166893005},{"id":"https://openalex.org/keywords/oral-bioavailability","display_name":"oral bioavailability","score":0.9190000295639038},{"id":"https://openalex.org/keywords/dissolution-rate","display_name":"dissolution rate","score":0.5070000290870667},{"id":"https://openalex.org/keywords/particle-size","display_name":"particle size","score":0.9369999766349792},{"id":"https://openalex.org/keywords/gastrointestinal-absorption","display_name":"gastrointestinal absorption","score":0.6690000295639038},{"id":"https://openalex.org/keywords/two-compartment-model","display_name":"two-compartment model","score":0.7369999885559082},{"id":"https://openalex.org/keywords/plasma-concentration-time-curve","display_name":"plasma concentration-time curve","score":0.5479999780654907},{"id":"https://openalex.org/keywords/healthy-female-volunteers","display_name":"healthy female volunteers","score":0.4449999928474426}],"concepts":[{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.9227612018585205},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.818119466304779},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.6570928692817688},{"id":"https://openalex.org/C2776306185","wikidata":"https://www.wikidata.org/wiki/Q2823834","display_name":"Medroxyprogesterone acetate","level":3,"score":0.6536223888397217},{"id":"https://openalex.org/C176685330","wikidata":"https://www.wikidata.org/wiki/Q857638","display_name":"Radioimmunoassay","level":2,"score":0.6532999277114868},{"id":"https://openalex.org/C125287762","wikidata":"https://www.wikidata.org/wiki/Q1758948","display_name":"Absorption (acoustics)","level":2,"score":0.5700938701629639},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5246617794036865},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.47557106614112854},{"id":"https://openalex.org/C3941253","wikidata":"https://www.wikidata.org/wiki/Q47270","display_name":"Half-life","level":3,"score":0.45670390129089355},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.40083640813827515},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.34744584560394287},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.08369386196136475},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.05882677435874939},{"id":"https://openalex.org/C159985019","wikidata":"https://www.wikidata.org/wiki/Q181790","display_name":"Composite material","level":1,"score":0.0},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001682","descriptor_name":"Biological Availability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006207","descriptor_name":"Half-Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007700","descriptor_name":"Kinetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008525","descriptor_name":"Medroxyprogesterone","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D008525","descriptor_name":"Medroxyprogesterone","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D008525","descriptor_name":"Medroxyprogesterone","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008525","descriptor_name":"Medroxyprogesterone","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008954","descriptor_name":"Models, Biological","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013607","descriptor_name":"Tablets","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017258","descriptor_name":"Medroxyprogesterone Acetate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1600-0773.1986.tb00115.x","doi":"https://doi.org/10.1111/j.1600-0773.1986.tb00115.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1600-0773.1986.tb00115.x","pdf_url":null,"source":{"id":"https://openalex.org/S4210230610","display_name":"Acta Pharmacologica et Toxicologica","issn_l":"0001-6683","issn":["0001-6683"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Pharmacologica et Toxicologica","raw_type":"journal-article"},{"id":"pmid:2943134","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2943134","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta pharmacologica et toxicologica","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320322581","display_name":"Vetenskapsr\u00e5det","ror":"https://ror.org/03zttf063"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":15,"referenced_works":["https://openalex.org/W42447759","https://openalex.org/W1976789089","https://openalex.org/W2001829834","https://openalex.org/W2001939227","https://openalex.org/W2003864838","https://openalex.org/W2018662196","https://openalex.org/W2024873028","https://openalex.org/W2058878155","https://openalex.org/W2098767652","https://openalex.org/W2166737192","https://openalex.org/W2275681653","https://openalex.org/W2418958283","https://openalex.org/W2502670554","https://openalex.org/W2920229824","https://openalex.org/W3204810137"],"related_works":["https://openalex.org/W43204403","https://openalex.org/W2038374393","https://openalex.org/W2003864838","https://openalex.org/W1971911156","https://openalex.org/W2418958283","https://openalex.org/W2384726172","https://openalex.org/W2363313565","https://openalex.org/W2048033938","https://openalex.org/W2024873028","https://openalex.org/W1969079639"],"abstract_inverted_index":{"The":[0,35,95,203],"pharmacokinetics":[1],"of":[2,16,19,68,88,92,109,116,155,208,221,237,247],"medroxyprogesterone":[3],"acetate":[4],"(MPA)":[5],"in":[6,41,204],"healthy":[7],"female":[8],"volunteers":[9],"have":[10],"been":[11],"investigated":[12],"following":[13,33],"oral":[14,71],"administration":[15,72,115,154],"single":[17],"doses":[18],"six":[20],"different":[21],"high-dose":[22],"MPA":[23,44,73,110,119,209,238,248],"tablet":[24,212],"formulations.":[25],"Blood":[26],"samples":[27],"were":[28,129,214],"obtained":[29],"over":[30],"96":[31],"hrs":[32,102],"administration.":[34],"plasma":[36,66,97,124],"was":[37,62],"separated":[38],"and":[39,105,133,138,146,173,196,216],"analyzed":[40],"duplicate":[42],"for":[43,142,177],"by":[45],"radioimmunoassay":[46],"(RIA)":[47],"after":[48,103],"extraction":[49],"with":[50,58,85,218],"petroleum":[51],"ether.":[52],"A":[53,145,181],"two":[54,240],"compartment":[55],"open":[56],"model":[57],"first":[59],"order":[60],"absorption":[61,90,246],"computer-fitted":[63],"to":[64,81,131,243],"the":[65,78,82,89,106,120,123,158,211,219,222,234,250],"concentration":[67,98],"MPA.":[69],"Following":[70,114,153],"is":[74,99,111],"rapidly":[75],"transferred":[76],"from":[77,210,249],"gastrointestinal":[79,251],"tract":[80],"blood":[83],"circulation":[84],"a":[86,227],"half-life":[87,108],"process":[91],"15-30":[93],"min.":[94],"peak":[96],"reached":[100],"1-3":[101],"administration,":[104],"biological":[107],"40-60":[112],"hrs.":[113],"1000":[117],"mg":[118,157],"areas":[121,159],"under":[122],"concentration-time":[125],"curves":[126],"(AUC":[127],"0-infinity)":[128],"calculated":[130],"(mean":[132],"S.E.):":[134],"3357":[135],"(438)":[136],"nmol/l":[137,141,176],"2403":[139],"(245)":[140],"Leo":[143,179,185],"formulation":[144,180,186],"Farlutal,":[147],"respectively":[148],"(P":[149,182,188,192,198],"less":[150,193,199],"than":[151,194,200],"0.02).":[152],"500":[156],"were:":[160],"2325":[161],"(389)":[162],"nmol/l,":[163,166,169,172],"1793":[164],"(312)":[165],"1778":[167],"(239)":[168],"1178":[170],"(209)":[171],"556":[174],"(89)":[175],"Gestapuran,":[178],"=":[183,189],"n.s.),":[184,190],"B":[187],"Provera":[191],"0.001),":[195,201],"Lutopolar":[197],"respectively.":[202],"vitro":[205],"dissolution":[206,229],"rates":[207],"formulations":[213],"determined":[215],"compared":[217],"results":[220],"bioavailability":[223],"studies,":[224],"indicating":[225],"that":[226],"rapid":[228],"rate":[230],"as":[231,233],"well":[232],"particle":[235],"size":[236],"are":[239],"important":[241],"factors":[242],"ensure":[244],"optimal":[245],"tract.":[252]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1978349904","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
